Penumbra reported positive data for a trial of its treatment for pulmonary embolism. The use of computer-assisted vacuum thrombectomy resulted in improvements in thrombus burden reduction, heart rate, ...

Pulmonary embolism (PE), a type of blood clot in the lungs, sends more than half a million people to U.S. hospitals each year—and kills about one in five high-risk patients, according to the American ...

Pulmonary embolism (PE), a type of blood clot in the lungs, sends more than half a million people to U.S. hospitals each year ...

for the treatment of acute intermediate-high risk pulmonary embolism (PE). "The latest STORM-PE findings demonstrate ...

Leslie Stoll was an active athlete who had never smoked. She was shocked when a chance scan spotted something unusual.

Dr. Andrew Klein, ENGULF National Co-Principal Investigator at Piedmont Hospital in Atlanta, today presented the positive ...

Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.

THROMBOLEX™, Inc. presented the prespecified interim analysis from the first 50 patients in RAPID-PE, a prospective, multicenter U.S. study evaluating On-The-Table (OTT) pharmaco-mechanical lysis (PML ...

Shares of medical device company Penumbra (NYSE:PEN) fell 5.5% in the afternoon session after the company announced results ...

CHEYENNE – Cheyenne Regional Medical Center (CRMC) announced Tuesday that it has achieved numerous distinctions for exceptional clinical performance from Healthgrades, the No. 1 site Americans use whe ...